Patent · US Active

Pharmaceutical composition for drug delivery

US11737980B2 · kind B2 · utility

2Cited by
20References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 2, 2021
Grant dateAug 29, 2023
Priority date
Expiry dateDec 2, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/0078
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

According to the invention, there is provided a pharmaceutically-acceptable composition which is preferably in the form of a spray-dried powder comprising a mixture of: Compositions are suitable for, for example, transmucosal drug delivery, including sublingual and nasal delivery. In the case of nasal delivery, said compositions may be loaded into single- or multiple-use nasal applicators. Preferred pharmaceutically-acceptable carriers in this regard include lactose or trehalose and dextrins (e.g. cyclodextrins or maltodextrins), which may be spray-dried together in combination. Compositions may further comprise one or more alkyl saccharides. Preferred alkyl saccharides include sucrose esters, such as sucrose monolaurate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.